Elisabeth Heere‐Ress

Author

University of Vienna

Also Known As

E Heere-Ress, E. Heere-Ress, Elisabeth Heere-Ress, Elisabeth Heere‐Ress

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Vienna Medical University of Vienna Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA Vienna General Hospital Ludwig Boltzmann Institute for Digital Health and Prevention

About

Elisabeth Heere‐Ress is an author at University of Vienna specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	977
2	Cell Biology	6	6	339
3	Engineering	1	1	10
4	Health Sciences	1	1	79
5	Allergy	1	1	22

Elisabeth Heere‐Ress

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Chemosensitisation of malignant melanoma by BCL2 antisense therapy Burkhard Jansen, Volker Wacheck, Elisabeth Heere‐Ress, The Lancet MedicineMelanomaImmune Checkpoint InhibitorMalignant MelanomaDermatology	2000	481
Bcl-2 Antisense Oligonucleotides (G3139) Inhibit Merkel Cell Carcinoma Growth in SCID Mice Hermine Schlagbauer‐Wadl, Gabriele Klosner, Elisabeth Heere‐Ress, Journal of Investigative Dermatology Tumor BiologyBcl-2 Antisense OligonucleotidesOncogenic AgentMedicineScid Mice	2000	99
Novel Ras antagonist blocks human melanoma growth Burkhard Jansen, Hermine Schlagbauer‐Wadl, Heike Kahr, Proceedings of the National Academy of Sciences	1999	97
Comparative Histopathology of Grey‐Horse‐Melanoma and Human Malignant Melanoma Monika Seltenhammer, Elisabeth Heere‐Ress, Sabine Brandt, Pigment Cell Research	2004	86
Adrenoceptor Hyporeactivity Is Responsible for <i>Escherichia coli</i> Endotoxin–Induced Acute Vascular Dysfunction in Humans Johannes Pleiner, Elisabeth Heere‐Ress, Herbert Langenberger, Arteriosclerosis Thrombosis and Vascular Biology	2002	82
The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. Edgar Selzer, Volker Wacheck, Trevor Lucas, PubMed PathologyCell ProliferationDermatologyCancer BiologyTumor Biology	2002	79
Bcl‐X<sub>L</sub> is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy Elisabeth Heere‐Ress, Christiane Thallinger, Trevor Lucas, International Journal of Cancer	2002	78
Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma Julia Valencak, Elisabeth Heere‐Ress, Tamara Kopp, European Journal of Cancer Blood VesselsMedicineMelanomaHistopathologyPathology	2003	61
Bcl-2 antisense oligonucleotides chemosensitize human gastric cancer in a SCID mouse xenotransplantation model Volker Wacheck, Elisabeth Heere‐Ress, Julius Halaschek-Wiener, Journal of Molecular Medicine Bcl-2 Antisense OligonucleotidesGastrointestinal OncologyMedicinePathologyCancer Genomics	2001	60
The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells Christoph Höeller, Christiane Thallinger, Barbara Pratscher, Journal of Investigative Dermatology Signal TransductionMetastatic BehaviorMedicineReceptor Tyrosine KinaseMelanoma	2005	47

Page 1